Deciphera Pharmaceuticals, LLC
Clinical trials sponsored by Deciphera Pharmaceuticals, LLC, explained in plain language.
A biopharmaceutical company developing kinase inhibitors for cancer, acquired by Ono Pharmaceutical.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug may weaken your birth control: study launches Results expected Oct 2026 (estimated)
- Could a cancer drug change how other medicines work? a trial investigates Results expected Dec 2026 (estimated)
- New combo therapy targets hard-to-treat GIST tumors Results expected Mar 2027 (estimated)
- New study tracks how TGCT patients fare on vimseltinib in everyday life Results expected Sep 2027 (estimated)
-
Experimental cancer pill tested in advanced tumors – trial halted early
Disease control Stopped earlyThis early-stage trial tested a new drug called DCC-3116 (inlexisertib) in 91 people with advanced or metastatic solid tumors that have RAS/MAPK pathway mutations. The drug was given alone or combined with other targeted therapies. The study aimed to find safe doses and check for…
Phase 1 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Experimental cancer drug DCC-3084 tested in early trial
Disease control Stopped earlyThis early-phase trial tested an oral drug called DCC-3084, alone or with other cancer treatments, in 29 people with advanced solid tumors that have MAPK pathway mutations (like certain lung, pancreatic, or skin cancers). The study aimed to find safe doses and see if tumors shrin…
Phase 1 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC